Skip to main content
. 2020 Jun 15;9(6):1465. doi: 10.3390/cells9061465

Figure 1.

Figure 1

Of the 8 patients with ALK-translocated tumors, 5 had detectable CTCs (Patients # 1–5); 4/5 of the CTC-positive patients had ALK-rearranged CTCs, the percentage of which is shown in the grey. In ALK-negative tumors, CTCs were detected in 7/12 cases (Patients # 6–12).